Orthostatic Hypotension
Key result
Orthostatic hypotension is independently linked to higher mortality, affecting ~30% of older adults.
Why the study?
Orthostatic hypotension is a common cardiovascular disorder with significant morbidity and mortality, yet its diagnosis, management, and implications require comprehensive synthesis.
Population
General population including patients with orthostatic hypotension
Design
Review article
Authors
Discussion
Loading...
Member takes
Implication
May warrant OH screening in elderly; leaves open whether algorithms reduce associated mortality and CV events.
Key Points
- To review the epidemiology, clinical presentation, and prognostic risks of orthostatic hypotension while outlining an updated diagnostic and therapeutic algorithm.
- Synthesized observational and clinical evidence regarding orthostatic hypotension defined by a standing systolic decrease of ≥20 mm Hg or diastolic decrease of ≥10 mm Hg.
- Evaluated prevalence distributions across age groups and associations with cardiovascular disease, neurodegenerative conditions, and overall mortality.
- Orthostatic hypotension prevalence increases significantly with age, occurring in 5% of adults under 50 years old and reaching 30% in individuals over 70 years old.
- The condition independently elevates all-cause mortality and increases the incidence of myocardial infarction, stroke, heart failure, and atrial fibrillation, even in asymptomatic patients.
- Postural blood pressure drops directly complicate management of preexisting coronary artery disease and hypertension, frequently causing falls, syncope, and traumatic injury.
Structured PICO
P
Population
General population and patients with orthostatic hypotension
Orthostatic hypotension is a common, age-dependent disorder that independently increases mortality and cardiovascular events, warranting careful diagnostic and therapeutic management.
Cite This Study
Ricci et al. (2015) conducted a review in Orthostatic hypotension. Orthostatic hypotension was evaluated. Orthostatic hypotension prevalence ranges from 5% in patients <50 years of age to 30% in those >70 years of age, and independently increases mortality and cardiovascular events.